Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-02-01
2011-02-01
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S263220, C514S263310, C514S263320, C514S263330
Reexamination Certificate
active
07879864
ABSTRACT:
Compounds for the treatment of elevated blood glucose levels and the physiological and metabolic disorders arising therefrom are disclosed which are inhibitors of the enzyme dipeptidyl peptidase IV (DDP-IV) and comprise novel substituted bicyclic 8-pyrrolidinoxanthines of formula I and their derivatives:wherein the various R-groups are defined herein. These compounds may be combined with other secondary active compounds which also are effective in the treatment of said disorders and the disease states or physiological manifestations arising therefrom.
REFERENCES:
patent: 2688618 (1954-09-01), Cooper, et. al.
patent: 4742065 (1988-05-01), Klosa et al.
patent: 5290801 (1994-03-01), Higley et al.
patent: 6143743 (2000-11-01), Wilde et al.
patent: 2007/0265284 (2007-11-01), Schoenafinger et al.
patent: 2009/0018148 (2009-01-01), Moureau et al.
patent: 2009/0163545 (2009-06-01), Goldfarb
patent: 1005517 (1957-04-01), None
patent: 0430300 (1990-11-01), None
patent: WO 92/05175 (1992-04-01), None
patent: WO 0063208 (2000-10-01), None
patent: WO 02068420 (2002-09-01), None
patent: WO 2004/048379 (2004-06-01), None
Kejha, J., et. al., Iodinated Phenoxyalkyltheophyllines, Cesko-Slovenska Farmacie (1966), vol. 15, No. 1 , pp. 2-4.
Truta, E., et. al., The Effects Induced by 8-(4-R)-Phenoxymethylxanthinic Compounds on Germination, Plantlet Growth and Mitosis in Allium Cept L, Analele Stiintifice Ale Universitatii Al. I. Cuza Din Iasi, Sectiunea 2A: Genetica Si Biologie Moieculara Bd. 2001, Nr. 1, Seiten 43-49XP002361403 Chemical Abstracts Service.
Blandine Laferrere et al., Effects of bombesin, of a new bombesin agonist (BIM187) and a new antagonist (BIM189) on food intake in rats, in relation to cholecystokinin, European Journal of Pharmocology, (1992), vol. 215(1), pp. 23-28.
Corri Black et al., Meglitinide analogues for type 2 diabetes melitus , The Cochrane Collaboration Review, (2007).
Krutovskikh, G. N., et al, Radioprotective Properties of Mercaoticaffeine Derivatives, Khimiko-Farmatsevticheskii Zhumal (1975), vol. 9(4), pp. 21-23, (Abstract Only).
Renzo Cescato et al., Bombesin Receptor Antagonists May Be Prefereable to Agonists for Tumor Targeting, The Journal of Nuclear Medicine, (2008), vol. 49(2), pp. 318-326.
1H-Purine-2, 6-Dione, 3,7-Dihydro-1, 3-Dimethyl-7-(Phenylmethyl)-8—[(2-(1-Pipenidinyl) Ethyl]Thio]=(9Cl) (CA Index Name), Chemical Abstracts Service Database Chemabs Online! XP002348284 (2001-2002).
Buning Christian
Defossa Elisabeth
Jaehne Gerhard
Schoenafinger Karl
Tschank Georg
Berch Mark L
Farquharson-Torres, Esq. Serena
Sanofi-Aventis Deutschland GmbH
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Substituted 8-aminoalkoxy-xanthine compounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 8-aminoalkoxy-xanthine compounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 8-aminoalkoxy-xanthine compounds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2628692